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Objective: To test the convenience of a new cooling technique with intravenous heat 
exchange catheters. Design: Retrospective chart review. Setting: University hospital 
neurointensive care unit. Patients: 20 patients with severe subarachnoid hemorrhage 
Hunt and Hess Grade 3 – 5 treated with mild hypothermia. Interventions: In all 
patients cooling to reach target body core temperature (33°C–34°C) was induced as 
quickly as possible. In the first 10 patients (group one) moderate hypothermia was 
induced and maintained using cooling blankets. In group two a 8.5F heat exchange 
catheter was placed central venous and temperature-adjusted normal saline 
circulated in a closed-loop system entailing two balloons. Measurements and results: 
A total of 2007 values of body core temperature (BCT) were registered every hour. 
Foley temperature catheters were used for monitoring BCT in the bladder. The time 
to reach the target BCT and the stability of temperature during hypothermia were 
compared between the two groups. No specific complications associated with the 
new cooling device were observed. Time to reach the target temperature in group 
two was significantly shorter than in group one (190+110 and 370+220 mins) 
(p=0.023). In group one significantly more temperature values were out of the target 
range (127 of 792 values;16.0%)  than in group two (62 of 1215 values;5.1%) 
(p<0.0001). Conclusions: The new endovascular cooling technique seems to be 
superior for rapid induction of hypothermia and maintaining temperature more stable 
than the cooling techniques using blankets and ice bags. 
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Animal and clinical studies show that hypothermia has the potential to limit the extent 
of secondary brain damage (1-11). Rapid cooling measures, stability of temperature 
during treatment and controlled rewarming are essential for optimal use of 
hypothermia. Currently, hypothermia is being induced by surface cooling using 
cooling blankets, skin washing with alcohol and ice bags. In a preliminary report in six 
patients with hemispheric infarction Georgiadis et al. suggest that induction and 
maintenance of hypothermia with a new intravenous cooling device are feasible (12) 
Nevertheless, to date no comparative studies with conventional cooling techniques 
were performed. 
The aim of the present study was to test the convenience and to examine 




Materials and methods 
 
From September 1999 to September 2001  20 patients (7 men and 13 woman) with 
subarachnoid hemorrhage (SAH) Hunt and Hess Grade 3 to 5 were treated with 
moderate hypothermia. The protocol was part of a project approved by the Ethics 
Committee of the University of Zürich (E-015/99). Informed consent was obtained by 
the next of kin or legal representatives. 
All patients were sedated (fentanyl infusion 5 - 8 ug/kg/h and midazolam 0.1 – 0.4 
mg/kg/h) and received neuromuscular blockade (atracurium 0.3 to 0.6 mg/kg/h). The 
patients were ventilated with a volume-controlled, pressure-regulated mode (EVITA 
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4, Dräger, Lübeck, Germany). Mean arterial pressure (MAP), cardiac output (CO), 
intrathoracic blood volume (ITBV) and extravascular lung water (EVLW) were 
monitored by a thermodilution catheter inserted in the femoral artery (PICCO system, 
Pulsion, Munich, Germany). Intracranial pressure (ICP) was monitored using 
ventricular catheters or subdural probes (NMT Neuroscience, Frankfurt, Germany) or 
intraparenchymatous sensors and transducers (Codman microsensor, Johnson & 
Johnson, Raynham). Body core temperature (BCT) values were registered every 
hour. Foley temperature catheters (temperature resolution 0.1°C) were used for 
monitoring BCT in the bladder (Mon-a-therm, Mallinckrodt, Hazelwood, MO, USA). 
Room temperature in the intensive care unit was between 20°C and 22°C. 
If  ICP increased above 15mmHg after early aneurysm surgery (day 0-1) patients 
were treated with drainage of cerebrospinal fluid, osmotherapy (Mannitol 20% and 
hypertonic  NaCl-hydroxyethyl-starch solution), mild hyperventilation and tris-hydroxy-
methyl-aminomethane (THAM) buffer. If these conventional methods failed to control 
elevated ICP, the patients were first treated with barbiturate coma. Barbiturate coma 
was induced with a thiopental loading dose of 10mg/kgBW, followed by a continuous 
infusion according to burst suppression pattern in continuous EEG. Nevertheless, 
instead of above listed treatment, if ICP continued to increase >15mmHg cooling to 
reach the target BCT of 33°C to 34°C was induced as quickly as possible. If ICP 
further increased > 15 mmHg a decompressive craniectomy with external 
decompression (removal of a large bone flap with dural patch with 
polyesterurethane/collagen) was performed. The target values for blood pressure 
management were adapted to reach cerebral perfusion pressure (CPP) values above 
70 mmHg. All patients were treated under extended monitoring of cerebral 
hemodynamics (monitoring of jugular bulb O2-saturation, cerebral blood flow or 
intraparenchymatous O2  partial pressure) (13,14). Hypothermia combined with 
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barbiturate coma was maintained depending on the course of ICP. Patients 
rewarming was initiated not before ICP remained stable <15 mmHg for more than 24 
hours. If CT control confirmed decrease of signs of brain edema patients were 
rewarmed no faster than 1°C per 24 hours. Normothermia thereafter was reached 
within two to three days.  
Between September 1999 and September 2000 in 10 patients (group one) 
moderate hypothermia was induced and maintained by surface cooling using cooling 
blankets (Bair HuggerTM, Augustine Medical, Saint Prarie; MN, USA and Blanketrol, 
CSZ, Cincinnatti; OH, USA) and ice bags on groin, axilla and neck. Between October 
2000 and October 2001 in group two a dual infusion lumen 8.5F 20 cm catheter was 
placed central venous via the subclavian vein into the superior vena cava or via the 
femoral vein into the vena illiaca (Cool Line Catheter, Alsius Corporation, Irvine, CA, 
USA). The catheter is furnished with an additional lumen, which ends in two balloons, 
sized 55 in lengths and 5x5 mm in diameter. The balloons are perfused with a sterile 
Ringerlactate solution via a closed-loop tubing system. The tubing system is 
connected to a temperature-management device (Coolgard System, Alsius 
Corporation, Irvine, CA, USA), consisting of a temperature adjustable water bath 
(0.5°C to 42°C) depending on the patient's own temperature. A pump circulates the 
Ringerlactate solution through the water bath.  
The following side effects of hypothermia were recorded: Pneumonia was defined 
as new infiltrates on chest x-ray combined with purulent tracheobronchial secretion. 
Sepsis was defined as systemic inflammatory response with underlying infection (15). 
Bradycardia (<40 beats per minute) and  cardiac arrythmias were documented. Signs 
of hemolysis were indicated by an increase of lactate dehydrogenase above two-fold 
values and confirmed by an increase of direct bilirubine in serum. 
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Complications of hypothermia, time to reach the target BCT, stability of 
temperature during hypothermia and Glasgow Outcome Score (GOS) were 
compared between the two groups. The time to reach the target BCT was calculated 
from the beginning of the Cool Line catheter installation until BCT target temperature 
< 34°C was reached. Neurological outcome was assessed after three months in the 
outpatient clinic by a neurologist, who was blinded to  the management of the 
patients during their ICU stay, using the Glasgow Outcome Score (GOS) (16), where 
GOS 1 denominates death, GOS 2 vegetative state (unable to interact with the 
environment), GOS 3 severe disability (unable to live independently but able to follow 
commands), GOS 4 moderate disability (capable of living independently but unable to 
return to work or school) and GOS 5 mild or no disability (able to return to work or 
school). Those patients who did not show up on control were contacted and asked 
about their functional status. 
 
Statistical analysis 
To compare the two groups the Mann-Whitney test was used; to compare the BCT 
values out of target range the Chi-square test was used.  Statistical significance was 





There were no differences concerning age, severity of SAH, duration of hypothermia 
and BCT before induction of hypothermia between the two patient groups (table 1). 
No specific complications associated using the new cooling device were observed. 
The catheters were carefully inspected upon removal. The balloons of all catheters 
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were intact and no thrombus formation was macroscopically visible. No signs of 
hemolysis, no relevant hematomas and no episode of severe bradycardia occurred. 
Possible complications of hypothermia are given in table 2. All 20 patients developed 
severe infections. Pneumonia occurred in 16 patients, one patient developed 
craniotomy wound infection and one patient with mycotic aneurysm developed 
endocarditis. Four patients developed sepsis syndrome. One patient in group two 
with coronary artery disease and preexisting hypertensive renal disease developed 
supraventricular tachycardia, successfully treated with amiodarone. Three patients, 
all in group one, died from severe ARDS (acute respiratory distress syndrome). 
Thrombocytopenia (< 100 000 platelets per cubic millimeter) occurred in seven 
patients. Serum levels of amylase were elevated (>53 U/L) in all patients but without 
other clinical or sonographic signs of pancreatitis. GOS in all patients, group one and 
two are given in table 3. Median GOS in all patients was 4. In group one GOSmedian 
was 2.5 and in group two 4.5. In all patients showing signs of systemic inflammatory 
response intravenous and intraarterial catheters were changed. In group two Cool 
Line catheters were not more often colonized with microorganisms (two from 16 
catheters; 12.5%) than other intravenous catheters (subclavian and jugular bulb 
catheters) (six from 34 catheters; 17.6%). 
In the 20 patients a total of 2007 values of body core temperature (BCT) were 
registered every hour (table 4). The mean duration of hypothermia in all patients was 
100+83 hours (range, 8 to 354 hours). The time needed for Cool Line catheter 
insertion ranged from 10 to 25 minutes. Mean time to reach the target temperature in 
group two was significantly shorter than in group one (190+110 and 370+220 mins) 
(p=0.023). In group one significantly more temperature values were out of the target 
range (127 of 792 values;16.0%) than in group two (62 of 1215 values;5.1%) 




Animal and clinical studies showed that moderate hypothermia has neuroprotective 
properties in severe traumatic brain injury, subarachnoid hemorrhage (SAH), and 
ischemia (3-7,9-11,17,18). Preliminary clinical studies suggest that moderate 
hypothermia may improve outcome in patients with malignant middle cerebral artery 
infarction and after cardiac arrest (8, 10, 11, 19). Nevertheless, in 50 patients with 
hemispheric infarction treated with moderate hypothermia 15 patients died during or 
after rewarming because of excessive ICP rise (8). The authors found that a shorter 
(<16 hours) rewarming period was associated with more pronounced increases in 
ICP and concluded that a longer period of controlled rewarming may limit  death 
caused by rebound edema. It is to be assumed that not only controlled rewarming but 
stability of temperature during treatment are most important for optimal use of 
hypothermia. With the new cooling technique less temperature values were out of the 
target range during maintenance of hypothermia.  
Furthermore, animal experiments indicate that hypothermia should be induced as 
early as possible in the course of illness (2,3,17,20-23). Moreover, in case of obese 
patients reaching the target BCT within time by surface cooling might be difficult (18). 
Therefore rapid and effective cooling measures are needed for induction of 
hypothermia. In the group with endovascular cooling time to insert the Cool Line 
catheter and to reach target BCT was in mean three hours, which was significantly 
shorter than in the group treated with conventional cooling techniques. Our results 
are comparable to the preliminary observations in six patients with hemispheric 
infarction made by Georgiadis et al. who reached the required target temperature in 3 
+ 1 hours (without catheter installation) (12).  
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BCT temperature was estimated from a thermistor catheter in the urinary bladder. 
Blood temperature as the standard for the BCT was monitored by a thermodilution 
catheter inserted in the femoral artery. Nevertheless, in group one these values were 
often influenced by ice bags on groin. Urinary bladder temperature monitoring has 
been shown to correlate well with the pulmonary arterial blood temperature (24). 
With the new endovascular cooling device no specific complications associated 
with the technique occurred. No signs of hemolysis and no relevant hematomas from 
puncture sites occurred. Thrombocytopenia and colonization with microorganisms did 
not appear more often when using the heat exchange catheters.  
Glasgow Outcome Score in the endovascular cooling group seems to be better 
than in the group treated with cooling blankets. Nevertheless, one might not conclude 
that the application of the new endovascular cooling device independently improves 
the outcome in patients treated with hypothermia after SAH. In the present study 
uncontrolled patient groups in consecutive time periods are compared 
retrospectively. Having become more experienced in hypothermia treatment over the 
two years period, other factors in neurointensive care management might have 
changed and influenced the outcome as well. 
In conclusion, the new endovascular cooling technique seems to be superior for 
rapid induction of hypothermia and maintaining temperature more stable than the 
cooling techniques using blankets and ice bags. It is to be assumed that during slow 
rewarming BCT is easier to control with the new device than with conventional 
techniques. To show the safety of the new technique and to examine whether the 
new method improves the outcome of patients treated with hypothermia, 
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Figure 1: Stability of temperature  
In group one significantly more temperature values were out of the target range of 
33-34°C (127 of 792 values;16.0%) than in group two (62 of 1215 values;5.1%). 
Scattergram and box and whiskers extending from the 25th to the 75th percentile 
show that BCT during hypothermia is more stable in group two. 
BCT, body core temperature 
 
 
 
 
